| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |